Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorSabiiti, Wilber
dc.contributor.authorMtafya, Bariki Anyamkisye
dc.contributor.authorAlferes De Lima, Daniela
dc.contributor.authorDombay, Evelin
dc.contributor.authorBaron, Vincent Olivier
dc.contributor.authorAzam, Khalide
dc.contributor.authorOrascova, Katarina
dc.contributor.authorSloan, Derek James
dc.contributor.authorGillespie, Stephen Henry
dc.date.accessioned2020-05-05T11:30:02Z
dc.date.available2020-05-05T11:30:02Z
dc.date.issued2020-04-30
dc.identifier.citationSabiiti , W , Mtafya , B A , Alferes De Lima , D , Dombay , E , Baron , V O , Azam , K , Orascova , K , Sloan , D J & Gillespie , S H 2020 , ' A tuberculosis molecular bacterial load assay (TB-MBLA) ' , Journal of Visualized Experiments , vol. 158 , e60460 . https://doi.org/10.3791/60460en
dc.identifier.issn1940-087X
dc.identifier.otherPURE: 261093330
dc.identifier.otherPURE UUID: 11feb7a0-de70-4c87-a62a-6204f5241064
dc.identifier.otherORCID: /0000-0001-6537-7712/work/73701289
dc.identifier.otherORCID: /0000-0002-4742-2791/work/73702088
dc.identifier.otherScopus: 85084786598
dc.identifier.otherORCID: /0000-0002-5125-1657/work/75997035
dc.identifier.otherWOS: 000530896100012
dc.identifier.otherORCID: /0000-0002-7888-5449/work/73701804
dc.identifier.urihttps://hdl.handle.net/10023/19879
dc.descriptionFunding: European and Developing Countries Clinical Trials Partnership (EDCTP) – Pan African Biomarker Expansion program (PanBIOME) grant SP.2011.41304.008. Support was also obtained the University of St Andrews School of Medicine research grant.en
dc.description.abstractTuberculosis is caused by Mycobacterium tuberculosis (Mtb), a pathogen classified by the United Nations (UN) as a dangerous category B biological substance. For the sake of the workers’ safety, handling of all samples presumed to carry Mtb must be conducted in a containment level (CL) 3 laboratory. The TB molecular bacterial load assay (TB-MBLA) test is a reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) test that quantifies Mtb bacillary load using primers and dual-labelled probes for 16S rRNA. We describe the use of heat inactivation to render TB samples noninfectious while preserving RNA for the TB-MBLA. A 1 mL aliquot of the sputum sample in tightly closed 15 mL centrifuge tubes is boiled for 20 min at either 80 °C, 85 °C, or 95 °C to inactivate Mtb bacilli. Cultivation of the heat inactivated and control (live) samples for 42 days confirmed the death of TB. The inactivated sample is then spiked with 100 µL of the extraction control and RNA is extracted following the standard RNA isolation procedure. No growth was observed in the cultures of heat treated samples. The isolated RNA is subjected to real-time RT-qPCR, which amplifies a specific target in the Mtb 16S rRNA gene, yielding results in the form of quantification cycles (Cq). A standard curve is used to translate Cq into bacterial load, or estimated colony forming units per mL (eCFU/mL). There is an inverse relationship between Cq and the bacterial load of a sample. The limitation is that heat inactivation lyses some cells, exposing the RNA to RNases that cause a loss of <1 log10eCFU/mL (i.e., <10 CFU/mL). Further studies will determine the proportion of very low burden patients that cause false negative results due to heat inactivation.
dc.format.extent10
dc.language.isoeng
dc.relation.ispartofJournal of Visualized Experimentsen
dc.rightsCopyright © 2020 the Authors. Creative Commons Attribution 3.0 License.en
dc.subjectQR Microbiologyen
dc.subjectDASen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subject.lccQRen
dc.titleA tuberculosis molecular bacterial load assay (TB-MBLA)en
dc.typeJournal articleen
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews. Infection and Global Health Divisionen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.contributor.institutionUniversity of St Andrews. Sir James Mackenzie Institute for Early Diagnosisen
dc.contributor.institutionUniversity of St Andrews. Centre for Biophotonicsen
dc.contributor.institutionUniversity of St Andrews. Global Health Implementation Groupen
dc.contributor.institutionUniversity of St Andrews. Gillespie Groupen
dc.contributor.institutionUniversity of St Andrews. Infection Groupen
dc.contributor.institutionUniversity of St Andrews. Biomedical Sciences Research Complexen
dc.identifier.doihttps://doi.org/10.3791/60460
dc.description.statusPeer revieweden


This item appears in the following Collection(s)

Show simple item record